|
New Anticoagulation Control for Toyobo-LVAS Using the CoaguChek XS®
|
（Department of Surgery, Kurume University School of Medicine, Kurume, Japan）
| Koji Akasu |
Ryusuke Mori |
Tomohiro Ueda |
| Hiroshi Tomoeda |
Koichi Arinaga |
Shuji Fukunaga |
| Shigeaki Aoyagi |
|
|
|
Aggressive anticoagulation therapy is necessary when Toyobo-LVAS is used for long-term treatment of severe heart failure.
However, it is necessary to regulate it carefully if there is a hemorrhagic complication due to thromboembolism, but repeated blood testing is painful.
We compared simple measurement with the CoaguChek XS® with the conventional blood testing method.
The correlation coefficient was 0.916, and the regression line was Y＝0.8027X＋0.3399. In addition,
drawing blood using the CoaguChek XS® was very effective in the reported pain reduction in patients.
Jpn. J. Cardiovasc. Surg. 40:31-33（2011）
Keywords：CoaguChek XS®, PT-INR, Toyobo-LVAS, anticoagulation therapy, warfarin
|
|
